Free Trial
→ My public warning after 55 years of watching the markets (From Weiss Ratings) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Lion One Metals Limited stock logo
LIO
Lion One Metals
C$0.13
-3.8%		C$0.16
C$0.12
▼
C$0.39
C$53.72M0.202015604,709 shs62,481 shs
SELLAS Life Sciences Group, Inc. stock logo
SLS
SELLAS Life Sciences Group
$7.86
-2.1%		$11.03
$1.39
▼
$15.88
$1.62B2.737.76 million shs11.12 million shs
10 Stocks Powering The Next AI Boom Cover
10 Stocks Powering The Next AI Boom

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Lion One Metals Limited stock logo
LIO
Lion One Metals
0.00%-3.85%-24.24%-10.71%-50.98%
SELLAS Life Sciences Group, Inc. stock logo
SLS
SELLAS Life Sciences Group
0.00%-6.65%-30.69%-38.50%+427.52%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Lion One Metals Limited stock logo
LIO
Lion One Metals
C$0.13
-3.8%		C$0.16
C$0.12
▼
C$0.39
C$53.72M0.202015604,709 shs62,481 shs
SELLAS Life Sciences Group, Inc. stock logo
SLS
SELLAS Life Sciences Group
$7.86
-2.1%		$11.03
$1.39
▼
$15.88
$1.62B2.737.76 million shs11.12 million shs
10 Stocks Powering The Next AI Boom Cover
10 Stocks Powering The Next AI Boom

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Lion One Metals Limited stock logo
LIO
Lion One Metals
0.00%-3.85%-24.24%-10.71%-50.98%
SELLAS Life Sciences Group, Inc. stock logo
SLS
SELLAS Life Sciences Group
0.00%-6.65%-30.69%-38.50%+427.52%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Lion One Metals Limited stock logo
LIO
Lion One Metals
4.00
Strong BuyN/AN/A
SELLAS Life Sciences Group, Inc. stock logo
SLS
SELLAS Life Sciences Group
2.33
Hold$10.0027.23% Upside

Current Analyst Ratings Breakdown

Latest LIO, SLS, BUT, and TRG Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/15/2026
SELLAS Life Sciences Group, Inc. stock logo
SLS
SELLAS Life Sciences Group
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
Reiterated RatingSell (D-)
(Data available from 11/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Lion One Metals Limited stock logo
LIO
Lion One Metals
C$76.53M0.70C$0.03 per share4.14C$0.38 per share0.33
SELLAS Life Sciences Group, Inc. stock logo
SLS
SELLAS Life Sciences Group
N/AN/AN/AN/A$0.46 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Lion One Metals Limited stock logo
LIO
Lion One Metals
-C$28.43MC$0.026.25N/AN/A7.78%2.96%-6.57%N/A
SELLAS Life Sciences Group, Inc. stock logo
SLS
SELLAS Life Sciences Group
-$26.86M-$0.21N/AN/AN/AN/A-33.96%-31.75%11/18/2026 (Estimated)

Latest LIO, SLS, BUT, and TRG Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/12/2026Q3 2026
SELLAS Life Sciences Group, Inc. stock logo
SLS
SELLAS Life Sciences Group
-$0.05-$0.05N/A-$0.05N/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Lion One Metals Limited stock logo
LIO
Lion One Metals
N/A2.30%N/AN/AN/A
SELLAS Life Sciences Group, Inc. stock logo
SLS
SELLAS Life Sciences Group
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Lion One Metals Limited stock logo
LIO
Lion One Metals
6.05
1.25
11.23
SELLAS Life Sciences Group, Inc. stock logo
SLS
SELLAS Life Sciences Group
N/A
18.83
18.83

Institutional Ownership

CompanyInstitutional Ownership
Lion One Metals Limited stock logo
LIO
Lion One Metals
0.07%
SELLAS Life Sciences Group, Inc. stock logo
SLS
SELLAS Life Sciences Group
17.38%

Insider Ownership

CompanyInsider Ownership
Lion One Metals Limited stock logo
LIO
Lion One Metals
8.09%
SELLAS Life Sciences Group, Inc. stock logo
SLS
SELLAS Life Sciences Group
1.30%
CompanyEmployeesShares OutstandingFree FloatOptionable
Lion One Metals Limited stock logo
LIO
Lion One Metals
509429.78 millionN/ANot Optionable
SELLAS Life Sciences Group, Inc. stock logo
SLS
SELLAS Life Sciences Group
13201.95 million199.32 millionOptionable

Recent News About These Companies

SELLAS Life Sciences Group (NASDAQ:SLS) Shares Gap Up - Here's Why
November 13 at 10:59 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-sellas-life-sciences-group-nasdaq-sls-shares-gap-up-heres-why-2026-11-13/
Sellas Life Sciences Stock Jumps on Trial Results Timeline
November 13 at 10:19 AM  |  schaeffersresearch.comhttps://www.schaeffersresearch.com/content/news/2026/11/13/sellas-life-sciences-stock-jumps-on-trial-results-timeline
SELLAS Life Sciences Group, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026
November 12 at 11:44 PM  |  marketscreener.comM
Sellas Life Sciences shares jump as key leukemia trial results near
November 12 at 11:44 PM  |  msn.comhttps://www.msn.com/en-us/money/top-stocks/sellas-life-sciences-shares-jump-as-key-leukemia-trial-results-near/ar-AA2hkTZM
SELLAS Life Sciences Group (SLS) Stock Forecast & Price Target
November 12 at 6:43 PM  |  tipranks.comhttps://www.tipranks.com/stocks/sls/forecast
SELLAS Life Sciences Reports Third Quarter 2026 Financial Results and Provides Corporate Update
November 12 at 4:05 PM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/11/12/3402212/0/en/sellas-life-sciences-reports-third-quarter-2026-financial-results-and-provides-corporate-update.html
SELLAS Life Sciences Group (SLS) Expected to Post Quarterly Earnings on Wednesday
November 11, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31190923
SLS stock rises after-hours: State Street reveals over 5% stake — and one fund manager boosted holdings by nearly 1,000%
November 10, 2026  |  msn.comhttps://www.msn.com/en-us/money/top-stocks/sls-stock-rises-after-hours-state-street-reveals-over-5-stake-and-one-fund-manager-boosted-holdings-by-nearly-1-000/ar-AA2haB1E
SELLAS Life Sciences Group (SLS) AI Stock Analysis
November 6, 2026  |  tipranks.comhttps://www.tipranks.com/stocks/sls/stock-analysis
SELLAS Life Sciences Group (SLS) Stock Could Be Fully Priced On Phase 3 Analysis Trigger
November 6, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/sellas-life-sciences-group-sls-051341902.html
Sellas Life Sciences: SLS009 Delivers Real Signals, but the Subgroup Math Demands a Closer Read
November 5, 2026  |  ad-hoc-news.deA
SLS stock rises overnight despite Citi’s 64% stake cut — retail bulls say SLS009 alone could outvalue Sellas
November 5, 2026  |  msn.comhttps://www.msn.com/en-in/news/other/sls-stock-rises-overnight-despite-citi-s-64-stake-cut-retail-bulls-say-sls009-alone-could-outvalue-sellas/ar-AA2gMZgU
SELLAS to present Phase 2 SLS009 data at ASH meeting in December
November 4, 2026  |  streetinsider.comhttps://www.streetinsider.com/FDA/SELLAS+to+present+Phase+2+SLS009+data+at+ASH+meeting+in+December/27287167.html
SELLAS Life Sciences to Present Positive Phase 2 Data Demonstrating Encouraging Response and Survival Outcomes with SLS009 Combination in High-Risk AML at ASH 2026
November 4, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/11/04/3395382/0/en/sellas-life-sciences-to-present-positive-phase-2-data-demonstrating-encouraging-response-and-survival-outcomes-with-sls009-combination-in-high-risk-aml-at-ash-2026.html
SLS stock snaps 4-day slide as retail eyes ASH abstracts — fresh filings reveal bigger Swiss, Arizona pension bets
November 3, 2026  |  msn.comhttps://www.msn.com/en-in/news/other/sls-stock-snaps-4-day-slide-as-retail-eyes-ash-abstracts-fresh-filings-reveal-bigger-swiss-arizona-pension-bets/ar-AA2gHor9
SELLAS Life Sciences Group Inc SLS
November 3, 2026  |  morningstar.comM
SELLAS Life Sciences Group (NASDAQ:SLS) Stock Crosses Below Two Hundred Day Moving Average - What's Next?
November 3, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31175531
SELLAS Life Sciences Group (NASDAQ:SLS) Shares Cross Below 200 Day Moving Average - Time to Sell?
November 3, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-sellas-life-sciences-group-nasdaq-sls-shares-cross-below-200-day-moving-average-time-to-sell-2026-11-03/
SLS stock hits over 1-month low: Retail bulls double down before cancer data — fresh filings show Q3 stake hikes of over 400%
November 3, 2026  |  msn.comhttps://www.msn.com/en-us/money/top-stocks/sls-stock-hits-over-1-month-low-retail-bulls-double-down-before-cancer-data-fresh-filings-show-q3-stake-hikes-of-over-400/ar-AA2gCY8s
Analysts Offer Insights on Healthcare Companies: Labcorp Holdings (LH), Bausch + Lomb Corporation (BLCO) and SELLAS Life Sciences Group (SLS)
October 30, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/BLCO-N/pressreleases/8560897/analysts-offer-insights-on-healthcare-companies-labcorp-holdings-lh-bausch-lomb-corporation-blco-and-sellas-life-sciences-group-sls/
SELLAS Life Sciences Group (SLS) Dropped, So What Is Behind The Latest Attention?
October 29, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/sellas-life-sciences-group-sls-231309689.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Salesforce cloud logo in a futuristic tech setting, highlighting CRM enterprise software and AI platform growth.
Salesforce Fuels AI Engine With $5.66B Braze Buyout
By Jeffrey Neal Johnson | October 21, 2026
Kinder Morgan logo over pipelines and an energy processing facility at sunset.
Why Kinder Morgan's Chairman Just Bought $15 Million in Stock
By Jeffrey Neal Johnson | November 10, 2026
An AAON branded HVAC cooling unit directs blue airflow through a data center server room with ductwork overhead.
Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
By Jeffrey Neal Johnson | November 11, 2026
AbbVie logo over a laboratory scene with vials, a pipette, and a DNA helix illustration.
AbbVie's Humira Era Is Fading, But Its New Growth Engines Face Another Test
By Thomas Hughes | November 2, 2026
A Boeing commercial aircraft parked on a tarmac at sunset, with the Boeing logo overlaid on the sky.
Boeing Got Its MAX 10 Approval, But Q3 Delivered a Reality Check
By Dan Schmidt | October 28, 2026
Lion One Metals stock logo

Lion One Metals CVE:LIO

C$0.12 -0.01 (-3.85%)
As of 11/13/2026 03:43 PM Eastern

Lion One Metals Limited engages in the acquisition, exploration, and evaluation of mineral resources in Fiji. The company's principal property is the 100% owned Tuvatu Gold project, which comprise four special prospecting licenses covering an area of approximately 13,613 hectares located on the island of Viti Levu in Fiji. Lion One Metals Limited is headquartered in North Vancouver, Canada.

SELLAS Life Sciences Group stock logo

SELLAS Life Sciences Group NASDAQ:SLS

$7.86 -0.17 (-2.12%)
Closing price 11/13/2026 04:00 PM Eastern
Extended Trading
$7.82 -0.04 (-0.52%)
As of 11/13/2026 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. The company's lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase 3 clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cancer. It has a strategic collaboration with Merck & Co., Inc. to evaluate GPS as it is administered in combination with PD1 blocker pembrolizumab in a Phase 1/2 clinical trial enrolling patients in up to five cancer indications, including hematologic malignancies and solid tumors; and GenFleet Therapeutics (Shanghai), Inc. for the development and commercialization of GFH009, a highly selective small molecule CDK9 inhibitor, currently under Phase 1 clinical trials. SELLAS Life Sciences Group, Inc. is headquartered in New York, New York.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas